Zobrazeno 1 - 8
of 8
pro vyhledávání: '"MJ Cumbraos Sánchez"'
Autor:
I Puértolas Tena, J Arribas García, JR Paño Pardo, MJ Cumbraos Sánchez, F. Ruiz Laiglesia, D Sánchez Fabra, S Gamarra Calvo, M.A. Allende Bandrés
Publikováno v:
Clinical pharmacy.
Background From October 2015, an Antimicrobial Stewardship Programme (ASP) was implemented in an internal medicine department by a multidisciplinary team. One of the interventions developed within this ASP was to promote the early switch of intraveno
Autor:
MA Alcácera López, MJ Cumbraos Sánchez, A Frutos Perez-Surio, B Bonaga Serrano, I Puértolas Tena, E Fernández Alonso, V Compaired Turlán, MA Sagredo Samanes
Publikováno v:
Clinical pharmacy.
Background Trastuzumab containing regimens are the standard of care for HER2+ breast cancer. While intravenous trastuzumab (Tiv) is administered as a weight based dose using an initial 90 min infusion followed by a subsequent 30 min infusion, subcuta
Autor:
E Guarc Prades, E Fernández Alonso, MJ Cumbraos Sánchez, MP Pardo Jario, M Merchante Andreu, M.A. Allende Bandrés, T Salvador Gómez, MA Alcácera López
Publikováno v:
European Journal of Hospital Pharmacy. 22:A190.1-A190
Background In June 2013, it was decided to start a protocol for the use of ranibizumab. Patients were grouped in order to fractionate vials in 0.5 ml syringes as a savings strategy under aseptic conditions. 3 doses of ranibizumab suitable for use are
Autor:
E Fernández Alonso, M.A. Allende Bandrés, M Merchante Andreu, MJ Cumbraos Sánchez, T Salvador Gómez, V Compaired Turlán, MA Alcácera López
Publikováno v:
European Journal of Hospital Pharmacy. 22:A60.1-A60
Background Metformin is one of the most commonly prescribed drugs for the treatment of type 2 DM. A potential complication of metformin is lactic acidosis (LA). This potential increased risk remains controversial. Purpose To evaluate the occurrence o
Autor:
M Gimeno Gracia, C Iñiguez Martinez, V Compaired Turlán, M Merchante Andreu, E Fernández Alonso, A Sanabria Sanchinel, MJ Cumbraos Sánchez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A63.1-A63
Background Multiple sclerosis (MS) is a chronic and progressive inflammatory disease that attacks the central nervous system. Impaired walking is the most significant disability; about half the patients suffer from this pathology 20 years after diagn
Publikováno v:
European Journal of Hospital Pharmacy. 22:A74.3-A75
Background A number of studies have shown that albumin is used wrongly in hospitals, basically related to its use in hypoalbuminaemia-hypoproteinaemia. Therefore, prescription of albumin should be limited to specific indications. Until recently, phar
Autor:
Sánchez Fabra D; Servicio de Medicina Interna, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España. Electronic address: davidsanchezfabra@gmail.com., Ruiz Laiglesia FJ; Servicio de Medicina Interna, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Pellejero Sagastizabal G; Servicio de Medicina Interna, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Cumbraos Sánchez MJ; Servicio de Farmacia Hospitalaria, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Olivera González S; Servicio de Medicina Interna, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Allende Bandrés MÁ; Servicio de Farmacia Hospitalaria, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Jimeno Sainz A; Servicio de Medicina Interna, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Vicente de Vera C; Servicio de Medicina Interna, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Sagredo Samanes MA; Servicio de Farmacia Hospitalaria, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Paño Pardo JR; Servicio de Enfermedades Infecciosas, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
Publikováno v:
Revista espanola de geriatria y gerontologia [Rev Esp Geriatr Gerontol] 2020 Jan - Feb; Vol. 55 (1), pp. 59-61. Date of Electronic Publication: 2019 Jul 25.
Autor:
Cumbraos-Sánchez MJ; Department of Hospital Pharmacy, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain; Instituto de Investigación Sanitaria de Aragón (IIS), Zaragoza, Spain., Hermoso R; Department of Computer Science and Systems Engineering, Universidad de Zaragoza, Zaragoza, Spain., Iñiguez D; Instituto de Biocomputación y Física de Sistemas Complejos (BIFI), Universidad de Zaragoza, Zaragoza, Spain; Fundación ARAID, Diputación General de Aragón, Zaragoza, Spain., Paño-Pardo JR; Instituto de Investigación Sanitaria de Aragón (IIS), Zaragoza, Spain; Department of Infectious Diseases, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Allende Bandres MÁ; Department of Hospital Pharmacy, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain; Instituto de Investigación Sanitaria de Aragón (IIS), Zaragoza, Spain. Electronic address: maallende@salud.aragon.es., Latorre Martinez MP; Department of Business Organisation and Management, Universidad de Zaragoza, Spain.
Publikováno v:
International journal of medical informatics [Int J Med Inform] 2019 Nov; Vol. 131, pp. 103955. Date of Electronic Publication: 2019 Aug 20.